Diabetes

The following information is intended for healthcare professionals

Supporting insulin-dependent diabetic patients

Wockhardt UK has been committed to the provision of porcine and bovine insulins for many years, recognising the medical needs and preferences of each individual person with diabetes.

Novo Nordisk's porcine insulin range has now been withdrawn.

The Department of Health fully accepts that some people are better suited to porcine or bovine insulin and that these insulins should continue to be made available. Because Wockhardt UK firmly believes in maintaining freedom of choice for those needing insulin, we can reassure you that:

Hypurin® porcine and bovine insulin will continue to be available for the foreseeable future.

Wockhardt UK is now working in partnership with BBI Healthcare. BBI Healthcare sales people have been briefed to discuss Hypurin® insulin. If you are a healthcare professional and would like a visit from a company representative, please contact our Marketing Department via the "Contact Us" page of this website.

Wockhardt UK also produces Glibenclamide, Gliclazide and Metformin tablets.

For a full Diabetes product listing, please select the Diabetes Therapy Area within the Product Search function.